Mark Dybul

Mark Dybul

Chief Executive Officer chez RENOVARO INC.

Fortune : 176 175 $ au 31/03/2024

60 ans
Commercial Services
Health Technology
Health Services

Profil

Mark Richard Dybul is currently the Executive Vice Chairman & Chief Executive Officer at Renovaro, Inc. He is also the Director at the Elton John AIDS Foundation, Inc., the International AIDS Vaccine Initiative, Inc., and the Elton John AIDS Foundation.
Additionally, he serves as the Faculty Co-Director & Professor at Georgetown University Medical Center and as a Director at Big Win Philanthropy and the National Academy of Medicine.
In the past, Dr. Dybul has worked as the Director of the Elizabeth Glaser Pediatric AIDS Foundation, the Executive Director of Management Sciences for Health, Inc., and the Executive Director of The Global Fund to Fight AIDS, Tuberculosis & Malaria.
He has also held positions as the Director of the National Institute of Allergy & Infectious Diseases, the Director of the Catholic Medical Mission Board, Inc., and the Director & Chief Medical Officer of the United States President's Emergency Plan for AIDS Relief.
Additionally, he served as the Co-Director-Global Health Law Program at the O'Neill Institute For National & Global Health Law.
Dr. Dybul obtained his undergraduate degree from Georgetown University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
13/02/2024 66 481 ( 0,05% ) 176 175 $ 31/03/2024

Postes actifs de Mark Dybul

SociétésPosteDébut
RENOVARO INC. Chief Executive Officer 20/07/2021
Georgetown University Medical Center Corporate Officer/Principal 01/06/2017
Director/Board Member -
Director/Board Member -
Director/Board Member -
National Academy of Medicine Corporate Officer/Principal -
Director/Board Member -
Tous les postes actifs de Mark Dybul

Anciens postes connus de Mark Dybul

SociétésPosteFin
The Global Fund to Fight AIDS, Tuberculosis & Malaria Director/Board Member 01/05/2017
O'Neill Institute For National & Global Health Law Director/Board Member 01/01/2012
░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░ ░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Voir l'expérience en détail de Mark Dybul

Formation de Mark Dybul

Georgetown University School of Medicine Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark Dybul

Relations

99

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
RENOVARO INC.

Health Technology

Entreprise privées12

Commercial Services

Commercial Services

Health Technology

Health Services

The Global Fund to Fight AIDS, Tuberculosis & Malaria

Commercial Services

National Institute of Allergy & Infectious Diseases

Government

Commercial Services

National Academy of Medicine

Commercial Services

Health Services

Commercial Services

O'Neill Institute For National & Global Health Law

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark Dybul